Rosuvastatin in older patients with systolic heart failure.

By J. Kjekshus, E. Apetrei, V. Barrios, M. Böhm, J. Cleland, J. Cornel, P. Dunselman, C. Fonseca, A. Goudev, P. Grande and 18 more. New England Journal of Medicine, 2007

788 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/f6ff6fe25af4112fb5b7c149408b77641129d229

Citations in the corpus

• Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association (2019, neutral): “Cardiomyopathy has never been associated with any statin, and in the 2 major trials of statin therapy in participants with heart failure, statins did not lead to symptomatic worsening of the condition or any increase in hospitalization.(35,36) The excess risk of myopathy relative to placebo is <0.”